One long accepted indicator of high‐risk NB and poor prognosis is amplification of the currently therapeutically intractable MYCN oncogene on chromosome 2p24, which is observed in 20–30% of all NB cases (Schwab et al, 1984; Brodeur, 2003; Maris et al, 2007). This evidence concerns the gene MYCN and neuroblastoma.